Showing results (51-60 of 147) with videos related to
Sort By:
Pageof 15
Nature Immunology|July 28, 2015
The ubiquitin-specific protease USP8 is critical for the development and homeostasis of T cellsAlmut Dufner, Agnes Kisser, Sandra Niendorf, et al.Plos One|August 14, 2023
The ubiquitin-like modifier FAT10 covalently modifies HUWE1 and strengthens the interaction of AMBRA1 and HUWE1Stefanie Mueller, Johanna Bialas, Stella Ryu, et al.Life Science Alliance|August 21, 2023
Tumor necrosis factor mediates USE1-independent FAT10ylation under inflammatory conditionsLeonie Schnell, Alina Zubrod, Nicola Catone, et al.Nature Reviews. Immunology|December 17, 2009
Proteasomes in immune cells: more than peptide producers?Marcus Groettrup, Christopher J Kirk, Michael BaslerMolecular Immunology|March 1, 2019
The ubiquitin-like modifier FAT10 is required for normal IFN-γ production by activated CD8<sup>+</sup> T cellsMei Min Mah, Michael Basler, Marcus GroettrupMolecular Immunology|February 26, 2008
Modulation of murine complement receptor type 2 (CR2/CD21) ectodomain shedding by its cytoplasmic domainMelanie M Hoefer, Annette Aichem, Andrew M Knight, et al.Molecular Immunology|February 4, 2017
Immunoproteasome subunit deficiency has no influence on the canonical pathway of NF-κB activationAnnegret Bitzer, Michael Basler, Daniel Krappmann, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|June 20, 2012
Coencapsulation of tumor lysate and CpG-ODN in PLGA-microspheres enables successful immunotherapy of prostate carcinoma in TRAMP miceMarc Mueller, Wilfried Reichardt, Julia Koerner, et al.International Journal of Cancer|January 6, 2011
Tumor eradication by immunotherapy with biodegradable PLGA microspheres--an alternative to incomplete Freund's adjuvantMarc Mueller, Eva Schlosser, Bruno Gander, et al.Molecular Immunology|June 6, 2017
No prolongation of skin allograft survival by immunoproteasome inhibition in miceSarah Mundt, Michael Basler, Birgit Sawitzki, et al.Pageof 15